Resources Contact Us Home
Humanized anti-CD70 binding agents and uses thereof

Image Number 17 for United States Patent #8067546.

Disclosed are CD70 binding agents, such as humanized anti-CD70 antibodies and fragments and derivatives, that exert a cytotoxic, cytostatic or immunomodulatory on CD70 expressing cells, as well as pharmaceutical compositions and kits comprising the antibody, fragment or derivative. Also disclosed are methods for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the CD70 binding agents or pharmaceutical compositions.

  Recently Added Patents
System and method of error reporting in a video distribution network
Powerline communication device with load characterization functionality
Receiving security risk feedback from linked contacts due to a user's system actions and behaviors
Transmission apparatus, receiving apparatus, method, and storage medium
Liposomes with improved drug retention for treatment of cancer
Integrated projector system
Method and apparatus for error correction in MBMS receipt system
  Randomly Featured Patents
Method of embedding hard cutting particles in a surface of a cutting edge of cutting tools, particularly saw blades, drills and the like
Light shade
Adjusting fixture
Method for obtaining biometric data for an individual in a secure transaction
Concurrent copy of system configuration global metadata
Low temperature arylamine processes
Method and apparatus for treatment of biological tissue
Electrical switch with contact spring
Constant-current VDDQ testing of integrated circuits
System and method for an automated broadcast system